Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).

Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).

Item
http://www.wikidata.org/entity/Q33796126
High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discoveryConvergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potentialThe chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulationPharmacologic activation of the innate immune system to prevent respiratory viral infections.Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in miceAdenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer.Using macrophage activation to augment immunotherapy of established tumours.Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compoundVadimezan: 2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid.Editorial: One small molecule: a new way to treat the flu?No difference in renal injury and fibrosis between wild-type and NOD1/NOD2 double knockout mice with chronic kidney disease induced by ureteral obstruction.
P2860

Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).

Item
http://www.wikidata.org/entity/Q33796126
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@ast
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
type
label
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@ast
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
prefLabel
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@ast
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932